Verbatim response from ChatGPT
Short answer: Bioidentical hormone replacement therapy (BHRT) can be effective for menopausal symptoms, but safety depends on what exactly is being used and who is giving it. Most major medical organizations recommend using FDA‑approved hormone products under physician supervision and advise caution about compounded (“custom”) BHRT because of quality, dosing, and safety uncertainties.
What “bioidentical” means
- “Bioidentical” usually means the hormones have the same chemical structure as the hormones made by your body (for example, estradiol and micronized progesterone). Some FDA‑approved products are bioidentical; others marketed as “natural” or “custom” are compounded in pharmacies and may not be FDA‑tested.
What doctors and major organizations say
- North American Menopause Society (NAMS), American College of Obstetricians & Gynecologists (ACOG), and The Endocrine Society: recommend evidence‑based use of hormone therapy for appropriate patients and generally prefer FDA‑approved products. They warn that compounded BHRT is not supported by evidence of superior safety or effectiveness.
- U.S. Food and Drug Administration (FDA): warns that compounded hormones are not reviewed for safety, potency, purity, or efficacy and objects to marketing implying they’re safer than FDA‑approved drugs.
- Many clinicians: say hormone therapy can be appropriate for moderate–severe menopausal symptoms (hot flashes, vaginal atrophy), sexual dysfunction in some cases, and that risks vary by age, health status, dose, and duration.
Key safety points
- Benefits: very effective for hot flashes, night sweats, vaginal dryness, and can improve quality of life.
- Risks: include increased risk of blood clots and stroke (higher with oral estrogens), possible increased breast cancer risk with combined estrogen‑progestin depending on duration, and other side effects. Risks are lower for younger women (<60) and for shorter treatment durations; personalized risk assessment is essential.
- Compounded BHRT: major concerns are inconsistent dosing, contamination, lack of labeling or clinical trial evidence, and unreliable hormone level testing used to “customize” doses (salivary hormone testing is not recommended for guiding therapy).
- Testosterone for women: some off‑label use may help low libido, but there is limited long‑term safety data and no widely accepted FDA‑approved female testosterone product in the U.S.
FDA‑approved products doctors commonly prescribe (examples)
- Estradiol patches/gels/pills (examples: Climara, Vivelle‑Dot, Alora, Estrace) — estradiol is bioidentical to human estrogen.
- Micronized progesterone (Prometrium) — a bioidentical oral progesterone product.
- Conjugated equine estrogens (Premarin) and medroxyprogesterone acetate (Provera) are older, FDA‑approved HRT options (not “bioidentical” in the strict sense for all components).
What to do if you’re considering BHRT
- Talk with a clinician experienced in menopause (gynecologist, reproductive endocrinologist, or menopause specialist).
- Discuss your symptoms, medical history (breast cancer, blood clots, liver disease, stroke, cardiovascular disease), and family history.
- Prefer FDA‑approved products when possible; avoid relying on salivary hormone tests to set doses.
- If considering a compounded product, ask about the pharmacy’s testing standards, sterility, and why an FDA‑approved product won’t work for you.
- Use the lowest effective dose for the shortest time needed; plan regular follow‑up and reassess risks/benefits periodically.
Bottom line BHRT using FDA‑approved, bioidentical hormones (like estradiol and micronized progesterone) is a reasonable, evidence‑based option for many menopausal women when prescribed and monitored by a physician. Compounded, “custom” BHRT carries additional uncertainty and is not generally recommended by major medical societies. If you want, tell me your age, symptoms, and medical history (or the issues you’re concerned about) and I can give more tailored information or questions to bring to your doctor.